The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia

By Tardito D.   Maina G.   Tura G.B.   Bogetto F.   Pioli R.   Ravizza L.   Racagni G.   Perez J.  

European Neuropsychopharmacology, Vol. 11, Iss. 3, 2001-06 ,pp. : 221-225

Elsevier

Access to resources Recommend Favorite

Tolerance to morphine at the -opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine

By Wang Z.   Sadee W.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 165-171

Elsevier

Access to resources Recommend Favorite

THE RESPONSIVENESS OF THE ENDOGENOUS INHIBITOR OF cAMP-DEPENDENT PROTEIN KINASE TO ISOPROTERENOL AFTER PROLONGED TREATMENT WITH NIFEDIPINE

By Zalewska-Kaszubska J.   Marczak G.   Wejman I.   Wiktorowska A.  

Pharmacological Research, Vol. 37, Iss. 2, 1998-02 ,pp. : 151-155

Academic Press

Access to resources Recommend Favorite

Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target

By Wójcik C.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 89-111

Informa Healthcare

Access to resources Recommend Favorite

Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies

By Martelli Alberto M   Chiarini Francesca   Evangelisti Camilla   Ognibene Andrea   Bressanin Daniela   Billi Anna Maria   Manzoli Lucia   Cappellini Alessandra   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 729-742

Informa Healthcare

Access to resources Recommend Favorite